A low-dose combination therapy of interleukin-2 and interferon-α is effective for lung metastasis of renal cell carcinoma: a multicenter open study

By Akaza Hideyuki   Tsukamoto Taiji   Onishi Tetsuro   Miki Tsuneharu   Kinouchi Toshiaki   Naito Seiji  

International Journal of Clinical Oncology, Vol. 11, Iss. 6, 2006-12 ,pp. : 434-440

Springer Publishing Company

Access to resources Recommend Favorite

A phase I clinical trial of low-dose interferon-α-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma

By Amato Robert   Khan Muhammad  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 1069-1073

Springer Publishing Company

Access to resources Recommend Favorite

Metastatic renal cell carcinoma treated with Peg-interferon alfa-2b

By Lyrdal David   Stierner Ulrika   Lundstam Sven  

Acta Oncologica, Vol. 48, Iss. 6, 2009-08 ,pp. : 901-908

Informa Healthcare

Access to resources Recommend Favorite

The Growth-Inhibitory Effects of Dexamethasone on Renal Cell Carcinoma In Vivo and In Vitro

By Arai Yasuyuki   Nonomura Norio   Nakai Yasutomo   Nishimura Kazou   Oka Daizo   Shiba Masahiro   Nakayama Masashi   Takayama Hitoshi   Mizutani Yoichi   Miki Tsuneharu   Okuyama Akihiko  

Cancer Investigation, Vol. 26, Iss. 1, 2007-12 ,pp. : 35-40

Informa Healthcare

Access to resources Recommend Favorite

Growth inhibition and cell-cycle arrest of human gastric cancer cells by Lycium barbarum polysaccharide

By Miao Ying   Xiao Bingxiu   Jiang Zhen   Guo Yanan   Mao Fang   Zhao Junwei   Huang Xia   Guo Junming  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 785-790

Humana Press, Inc

Access to resources Recommend Favorite